Hurtado-Navarro L, Baroja-Mazo A, Martinez-Banaclocha H, Pelegrin P. Assessment of ASC Oligomerization by Flow Cytometry. Methods Mol Biol. 2022;2459:1-9. doi: 10.1007/978-1-0716-2144-8_1. PubMed PMID: 35212949.
AÑO: 2022
|
Hurtado-Navarro L, Baroja-Mazo A, Pelegrin P. Characterization of P2X7 Receptors in Human Blood Cells. Methods Mol Biol. 2022;2510:279-290. doi: 10.1007/978-1-0716-2384-8_15. PubMed PMID: 35776331.
AÑO: 2022
|
Hurtado-Navarro L, Angosto-Bazarra D, Pelegrin P, Baroja-Mazo A, Cuevas S. NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers. Antioxidants (Basel). 2022 Apr 28;11(5):870. doi: 10.3390/antiox11050870. PubMed PMID: 35624734; PubMed Central PMCID: PMC9137763.
AÑO: 2022; IF: 7.675
|
Garcia-Villalba J, Hurtado-Navarro L, Penin-Franch A, Molina-Lopez C, Martinez-Alarcon L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P. Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity. Front Immunol. 2022 May 18;13:894470. doi: 10.3389/fimmu.2022.894470. eCollection 2022. PubMed PMID: 35663992; PubMed Central PMCID: PMC9161710.
AÑO: 2022; IF: 7.3
|
Tapiz I Reula AJ, Cochino AV, Martins AL, Angosto-Bazarra D, de Landazuri IO, Mensa-Vilaro A, Cabral M, Baroja-Mazo A, Banos MC, Lobato-Salinas Z, Fabregat V, Plaza S, Yague J, Casals F, Oliva B, Figueiredo AE, Pelegrin P, Arostegui JI. Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome. J Clin Immunol. 2022 Oct;42(7):1421-1432. doi: 10.1007/s10875-022-01298-2. Epub 2022 Jun 18. Erratum In: J Clin Immunol. 2022 Jul 8;: PubMed PMID: 35716229; PubMed Central PMCID: PMC9674708.
AÑO: 2022; IF: 9.1
|